{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T10:59:23Z","timestamp":1764586763743},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,5,24]],"date-time":"2011-05-24T00:00:00Z","timestamp":1306195200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s00784-011-0567-2","type":"journal-article","created":{"date-parts":[[2011,5,23]],"date-time":"2011-05-23T05:02:13Z","timestamp":1306126933000},"page":"735-744","source":"Crossref","is-referenced-by-count":22,"title":["Efficacy of taurolidine against periodontopathic species\u2014an in vitro study"],"prefix":"10.1007","volume":"16","author":[{"given":"Sigrun","family":"Eick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Radakovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Pfister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandor","family":"Nietzsche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton","family":"Sculean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,24]]},"reference":[{"key":"567_CR1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0378-1097(03)00611-6","volume":"226","author":"GB Schuller-Levis","year":"2003","unstructured":"Schuller-Levis GB, Park E (2003) Taurine: new implications for an old amino acid. FEMS Microbiol Lett 226:195\u2013202","journal-title":"FEMS Microbiol Lett"},{"key":"567_CR2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00726-005-0238-1","volume":"30","author":"JM Engel","year":"2006","unstructured":"Engel JM, Muhling J, Weiss S, Karcher B, Lohr T, Menges T, Little S, Hempelmann G (2006) Relationship of taurine and other amino acids in plasma and in neutrophils of septic trauma patients. Amino Acids 30:87\u201394","journal-title":"Amino Acids"},{"key":"567_CR3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2672.1987.tb04926.x","volume":"62","author":"SP Gorman","year":"1987","unstructured":"Gorman SP, McCafferty DF, Woolfson AD, Jones DS (1987) Reduced adherence of micro-organisms to human mucosal epithelial cells following treatment with Taurolin, a novel antimicrobial agent. J Appl Bacteriol 62:315\u2013320","journal-title":"J Appl Bacteriol"},{"key":"567_CR4","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/1043-4666(91)90483-T","volume":"3","author":"I Bedrosian","year":"1991","unstructured":"Bedrosian I, Sofia RD, Wolff SM, Dinarello CA (1991) Taurolidine, an analogue of the amino acid taurine, suppresses interleukin 1 and tumor necrosis factor synthesis in human peripheral blood mononuclear cells. Cytokine 3:568\u2013575","journal-title":"Cytokine"},{"key":"567_CR5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/jlb.47.4.321","volume":"47","author":"G Schuller-Levis","year":"1990","unstructured":"Schuller-Levis G, Mehta PD, Rudelli R, Sturman J (1990) Immunologic consequences of taurine deficiency in cats. J Leukoc Biol 47:321\u2013331","journal-title":"J Leukoc Biol"},{"key":"567_CR6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/978-1-4615-3436-5_38","volume":"315","author":"RE Gordon","year":"1992","unstructured":"Gordon RE, Heller RF (1992) Taurine protection of lungs in hamster models of oxidant injury: a morphologic time study of paraquat and bleomycin treatment. Adv Exp Med Biol 315:319\u2013328","journal-title":"Adv Exp Med Biol"},{"key":"567_CR7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0195-6701(80)90057-2","volume":"1","author":"S Brearley","year":"1980","unstructured":"Brearley S, George RH (1980) The rate of antimicrobial action of noxythiolin and taurolin. J Hosp Infect 1:201\u2013209","journal-title":"J Hosp Infect"},{"key":"567_CR8","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1177\/0091270007299929","volume":"47","author":"L Gong","year":"2007","unstructured":"Gong L, Greenberg HE, Perhach JL, Waldman SA, Kraft WK (2007) The pharmacokinetics of taurolidine metabolites in healthy volunteers. J Clin Pharmacol 47:697\u2013703","journal-title":"J Clin Pharmacol"},{"key":"567_CR9","doi-asserted-by":"crossref","unstructured":"Rohner E, Kolar P, Seeger JB, Arnholdt J, Thiele K, Perka C, Matziolis G (2011) Toxicity of antiseptics against chondrocytes: what is best for the cartilage in septic joint surgery? Int Orthop (in press)","DOI":"10.1007\/s00264-010-1178-2"},{"key":"567_CR10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/MPG.0b013e318162c428","volume":"47","author":"JH Bradshaw","year":"2008","unstructured":"Bradshaw JH, Puntis JW (2008) Taurolidine and catheter-related bloodstream infection: a systematic review of the literature. J Pediatr Gastroenterol Nutr 47:179\u2013186","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"567_CR11","first-page":"78","volume":"34","author":"C Burri","year":"1990","unstructured":"Burri C (1990) Treatment of local infection with taurolin. Aktuelle Probl Chir Orthop 34:78\u201384","journal-title":"Aktuelle Probl Chir Orthop"},{"key":"567_CR12","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/01.cad.0000176502.40810.b0","volume":"16","author":"CA Jacobi","year":"2005","unstructured":"Jacobi CA, Menenakos C, Braumann C (2005) Taurolidine\u2014a new drug with anti-tumor and anti-angiogenic effects. Anticancer Drugs 16:917\u2013921","journal-title":"Anticancer Drugs"},{"key":"567_CR13","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1902\/jop.2001.72.3.374","volume":"72","author":"M Soete De","year":"2001","unstructured":"De Soete M, Mongardini C, Peuwels M, Haffajee A, Socransky S, van Steenberghe D, Quirynen M (2001) One-stage full-mouth disinfection. Long-term microbiological results analyzed by checkerboard DNA-DNA hybridization. J Periodontol 72:374\u2013382","journal-title":"J Periodontol"},{"key":"567_CR14","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1902\/jop.2007.060222","volume":"78","author":"J Cosyn","year":"2007","unstructured":"Cosyn J, Sabzevar MM (2007) Subgingival chlorhexidine varnish administration as an adjunct to same-day full-mouth root planing. II. Microbiological observations. J Periodontol 78:438\u2013445","journal-title":"J Periodontol"},{"key":"567_CR15","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1902\/jop.2007.060221","volume":"78","author":"J Cosyn","year":"2007","unstructured":"Cosyn J, Wyn I, De Rouck T, Sabzevar MM (2007) Subgingival chlorhexidine varnish administration as an adjunct to same-day full-mouth root planing. I. Clinical observations. J Periodontol 78:430\u2013437","journal-title":"J Periodontol"},{"key":"567_CR16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0887-2333(01)00020-0","volume":"15","author":"E Hidalgo","year":"2001","unstructured":"Hidalgo E, Dominguez C (2001) Mechanisms underlying chlorhexidine-induced cytotoxicity. Toxicol In Vitro 15:271\u2013276","journal-title":"Toxicol In Vitro"},{"key":"567_CR17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00784-006-0094-8","volume":"11","author":"CT Cabral","year":"2007","unstructured":"Cabral CT, Fernandes MH (2007) In vitro comparison of chlorhexidine and povidone-iodine on the long-term proliferation and functional activity of human alveolar bone cells. Clin Oral Investig 11:155\u2013164","journal-title":"Clin Oral Investig"},{"key":"567_CR18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-0765.1989.tb00871.x","volume":"24","author":"PJ Oosterwaal","year":"1989","unstructured":"Oosterwaal PJ, Mikx FH, van den Brink ME, Renggli HH (1989) Bactericidal concentrations of chlorhexidine-digluconate, amine fluoride gel and stannous fluoride gel for subgingival bacteria tested in serum at short contact times. J Periodontal Res 24:155\u2013160","journal-title":"J Periodontal Res"},{"key":"567_CR19","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1034\/j.1600-051X.2002.290809.x","volume":"29","author":"M Feres","year":"2002","unstructured":"Feres M, Haffajee AD, Allard K, Som S, Goodson JM, Socransky SS (2002) Antibiotic resistance of subgingival species during and after antibiotic therapy. J Clin Periodontol 29:724\u2013735","journal-title":"J Clin Periodontol"},{"key":"567_CR20","unstructured":"CLSI (2007) Clinical and Laboratory Standards Institute (formerly NCCLS). Methods for antimicrobial susceptibility testing of anaerobic bacteria; Approved standard \u2013 seventh edition. CLSI document 27:M11-A7"},{"key":"567_CR21","unstructured":"CLSI (2009) Clinical and Laboratory Standards Institute (formerly NCCLS). Performance standards for antimicrobial disk susceptibility tests, 5th ed. CLSI document 29:M02-A9"},{"key":"567_CR22","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF01266009","volume":"353","author":"MM Linder","year":"1981","unstructured":"Linder MM, Ott W, Wesch G, Wicki O, Marti MC, Moser G (1981) Therapy of purulent peritonitis. Documentation of 78 cases and experience with taurolin (author's transl). Langenbecks Arch Chir 353:241\u2013250","journal-title":"Langenbecks Arch Chir"},{"issue":"Suppl 1","key":"567_CR23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1034\/j.1601-0825.9.s1.5.x","volume":"9","author":"PC Baehni","year":"2003","unstructured":"Baehni PC, Takeuchi Y (2003) Anti-plaque agents in the prevention of biofilm-associated oral diseases. Oral Dis 9(Suppl 1):23\u201329","journal-title":"Oral Dis"},{"key":"567_CR24","first-page":"13","volume":"13","author":"S Reynolds","year":"1991","unstructured":"Reynolds S, Moran J, Addy M, Wade WG, Newcombe R (1991) Taurolin as an oral rinse. I. Antimicrobial effects in vitro and in vivo. Clin Prev Dent 13:13\u201317","journal-title":"Clin Prev Dent"},{"key":"567_CR25","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1128\/AAC.46.6.1674-1679.2002","volume":"46","author":"CB Shah","year":"2002","unstructured":"Shah CB, Mittelman MW, Costerton JW, Parenteau S, Pelak M, Arsenault R, Mermel LA (2002) Antimicrobial activity of a novel catheter lock solution. Antimicrob Agents Chemother 46:1674\u20131679","journal-title":"Antimicrob Agents Chemother"},{"key":"567_CR26","first-page":"130","volume":"31","author":"M Zimmermann","year":"1993","unstructured":"Zimmermann M, Preac-Mursic V (1993) The antimicrobial actions of taurolin and other preparations on the pathogenic spectrum in dentoalveolar infections. Int J Clin Pharmacol Ther Toxicol 31:130\u2013136","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"567_CR27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0014-5793(81)80210-4","volume":"127","author":"MJ Gidley","year":"1981","unstructured":"Gidley MJ, Sanders JK, Myers ER, Allwood MC (1981) The mode of antibacterial action of some 'masked' formaldehyde compounds. FEBS Lett 127:225\u2013227","journal-title":"FEBS Lett"},{"key":"567_CR28","doi-asserted-by":"crossref","first-page":"e8927","DOI":"10.1371\/journal.pone.0008927","volume":"5","author":"F Caruso","year":"2010","unstructured":"Caruso F, Darnowski JW, Opazo C, Goldberg A, Kishore N, Agoston ES, Rossi M (2010) Taurolidine antiadhesive properties on interaction with E. coli; its transformation in biological environment and interaction with bacteria cell wall. PLoS ONE 5:e8927","journal-title":"PLoS ONE"},{"key":"567_CR29","unstructured":"Newman MG, van Winkelhoff AJ (2001) Antibiotic and antimicrobial use in dental practice.Second edition. Quintessence Publishing Co, Inc, Chicago, Berlin, London, Tokyo, Paris, Barcelona, Sao Paulo, Moscow, Prague, and Warsaw"},{"key":"567_CR30","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1902\/jop.2008.070589","volume":"79","author":"AR Pradeep","year":"2008","unstructured":"Pradeep AR, Sagar SV, Daisy H (2008) Clinical and microbiologic effects of subgingivally delivered 0.5% azithromycin in the treatment of chronic periodontitis. J Periodontol 79:2125\u20132135","journal-title":"J Periodontol"},{"key":"567_CR31","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1902\/jop.1998.69.10.1085","volume":"69","author":"NH Stoller","year":"1998","unstructured":"Stoller NH, Johnson LR, Trapnell S, Harrold CQ, Garrett S (1998) The pharmacokinetic profile of a biodegradable controlled-release delivery system containing doxycycline compared to systemically delivered doxycycline in gingival crevicular fluid, saliva, and serum. J Periodontol 69:1085\u20131091","journal-title":"J Periodontol"},{"key":"567_CR32","first-page":"72","volume":"4","author":"TE Dyke Van","year":"2002","unstructured":"Van Dyke TE, Offenbacher S, Braswell L, Lessem J (2002) Enhancing the value of scaling and root-planing: arestin clinical trial results. J Int Acad Periodontol 4:72\u201376","journal-title":"J Int Acad Periodontol"},{"key":"567_CR33","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1128\/IAI.49.3.487-493.1985","volume":"49","author":"JG Tew","year":"1985","unstructured":"Tew JG, Marshall DR, Burmeister JA, Ranney RR (1985) Relationship between gingival crevicular fluid and serum antibody titers in young adults with generalized and localized periodontitis. Infect Immun 49:487\u2013493","journal-title":"Infect Immun"},{"key":"567_CR34","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.2042-7158.1990.tb07066.x","volume":"42","author":"JI Blenkharn","year":"1990","unstructured":"Blenkharn JI (1990) In-vitro antibacterial activity of noxythiolin and taurolidine. J Pharm Pharmacol 42:589\u2013590","journal-title":"J Pharm Pharmacol"},{"key":"567_CR35","doi-asserted-by":"crossref","first-page":"e1000316","DOI":"10.1371\/journal.ppat.1000316","volume":"5","author":"M Potempa","year":"2009","unstructured":"Potempa M, Potempa J, Kantyka T, Nguyen KA, Wawrzonek K, Manandhar SP, Popadiak K, Riesbeck K, Eick S, Blom AM (2009) Interpain A, a cysteine proteinase from Prevotella intermedia, inhibits complement by degrading complement factor C3. PLoS Pathog 5:e1000316","journal-title":"PLoS Pathog"},{"key":"567_CR36","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.4049\/jimmunol.181.8.5537","volume":"181","author":"M Potempa","year":"2008","unstructured":"Potempa M, Potempa J, Okroj M, Popadiak K, Eick S, Nguyen KA, Riesbeck K, Blom AM (2008) Binding of complement inhibitor C4b-binding protein contributes to serum resistance of Porphyromonas gingivalis. J Immunol 181:5537\u20135544","journal-title":"J Immunol"},{"key":"567_CR37","first-page":"18","volume":"13","author":"S Reynolds","year":"1991","unstructured":"Reynolds S, Moran J, Wade WG, Addy M, Newcombe R (1991) Taurolin as an oral rinse. II. Effects on in vitro and in vivo plaque regrowth. Clin Prev Dent 13:18\u201322","journal-title":"Clin Prev Dent"},{"key":"567_CR38","doi-asserted-by":"crossref","unstructured":"Arweiler NB, Auschill TM, Sculean A (2011) Antibacterial effect of taurolidine (2%) on established dental plaque biofilm. Clin Oral Investig (in press)","DOI":"10.1007\/s00784-011-0526-y"},{"key":"567_CR39","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1053\/j.ajkd.2009.11.025","volume":"55","author":"LR Solomon","year":"2010","unstructured":"Solomon LR, Cheesbrough JS, Ebah L, Al-Sayed T, Heap M, Millband N, Waterhouse D, Mitra S, Curry A, Saxena R, Bhat R, Schulz M, Diggle P (2010) A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis. Am J Kidney Dis 55:1060\u20131068","journal-title":"Am J Kidney Dis"},{"key":"567_CR40","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ijantimicag.2009.12.011","volume":"35","author":"N Hoiby","year":"2010","unstructured":"Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O (2010) Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 35:322\u2013332","journal-title":"Int J Antimicrob Agents"},{"key":"567_CR41","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1902\/jop.2008.080233","volume":"79","author":"DL Cochran","year":"2008","unstructured":"Cochran DL (2008) Inflammation and bone loss in periodontal disease. J Periodontol 79:1569\u20131576","journal-title":"J Periodontol"},{"key":"567_CR42","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1128\/IAI.63.10.3878-3885.1995","volume":"63","author":"RJ Lamont","year":"1995","unstructured":"Lamont RJ, Chan A, Belton CM, Izutsu KT, Vasel D, Weinberg A (1995) Porphyromonas gingivalis invasion of gingival epithelial cells. Infect Immun 63:3878\u20133885","journal-title":"Infect Immun"},{"key":"567_CR43","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1034\/j.1399-302X.2002.170401.x","volume":"17","author":"S Eick","year":"2002","unstructured":"Eick S, Rodel J, Einax JW, Pfister W (2002) Interaction of Porphyromonas gingivalis with KB cells: comparison of different clinical isolates. Oral Microbiol Immunol 17:201\u2013208","journal-title":"Oral Microbiol Immunol"},{"key":"567_CR44","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1600-0765.2008.01113.x","volume":"44","author":"A Guentsch","year":"2009","unstructured":"Guentsch A, Puklo M, Preshaw PM, Glockmann E, Pfister W, Potempa J, Eick S (2009) Neutrophils in chronic and aggressive periodontitis in interaction with Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans. J Periodontal Res 44:368\u2013377","journal-title":"J Periodontal Res"},{"key":"567_CR45","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/978-0-387-33504-9_54","volume":"583","author":"J Marcinkiewicz","year":"2006","unstructured":"Marcinkiewicz J, Kurnyta M, Biedron R, Bobek M, Kontny E, Maslinski W (2006) Anti-inflammatory effects of taurine derivatives (taurine chloramine, taurine bromamine, and taurolidine) are mediated by different mechanisms. Adv Exp Med Biol 583:481\u2013492","journal-title":"Adv Exp Med Biol"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-011-0567-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00784-011-0567-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-011-0567-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T12:25:49Z","timestamp":1592569549000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00784-011-0567-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,24]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["567"],"URL":"https:\/\/doi.org\/10.1007\/s00784-011-0567-2","relation":{},"ISSN":["1432-6981","1436-3771"],"issn-type":[{"value":"1432-6981","type":"print"},{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,24]]}}}